Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Medicines Patent Pool
Pharma
Novartis will let generic Tasigna to be provided to poor nations
The Medicines Patent Pool has signed up four generic drugmakers to produce copycats of Novartis’ myeloid leukemia drug Tasigna for poorer nations.
Kevin Dunleavy
Jun 23, 2023 10:01am
Viatris, Cipla and Aurobindo sign up to make GSK PrEP generics
Mar 30, 2023 2:00am
Pfizer pledges to sell all products at cost to poor countries
Jan 17, 2023 9:50am
GSK feeds HIV PrEP drug to patent pool amid US launch
Jul 28, 2022 10:00am
ViiV is working to expand access on its latest HIV approval
May 27, 2022 8:25am
BMS, Novartis, Roche join new coalition for cancer drug access
May 20, 2022 10:50am
